Astria Therapeutics, Inc. (ATXS)
NASDAQ: ATXS · Real-Time Price · USD
4.050
+0.150 (3.85%)
May 14, 2025, 10:18 AM - Market open
Astria Therapeutics Market Cap
Astria Therapeutics has a market cap or net worth of $228.56 million as of May 14, 2025. Its market cap has decreased by -53.74% in one year.
Market Cap
228.56M
Enterprise Value
-69.91M
1-Year Change
-53.74%
Ranking
Category
Stock Price
$4.05
Market Cap Chart
Since June 25, 2015, Astria Therapeutics's market cap has increased from $180.00M to $228.56M, an increase of 26.98%. That is a compound annual growth rate of 2.44%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 13, 2025 | 220.10M | -56.37% |
| Dec 31, 2024 | 504.50M | 80.95% |
| Dec 29, 2023 | 278.80M | 11.30% |
| Dec 30, 2022 | 250.50M | 257.35% |
| Dec 31, 2021 | 70.10M | 63.02% |
| Dec 31, 2020 | 43.00M | -38.31% |
| Dec 31, 2019 | 69.70M | 124.84% |
| Dec 31, 2018 | 31.00M | -9.88% |
| Dec 29, 2017 | 34.40M | -48.89% |
| Dec 30, 2016 | 67.30M | -44.52% |
| Dec 31, 2015 | 121.30M | -32.61% |
View and export this data all the way back to 2015.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 669.76B |
| Johnson & Johnson | 357.16B |
| AbbVie | 332.08B |
| Novo Nordisk | 291.59B |
| UnitedHealth Group | 282.47B |
| Abbott Laboratories | 224.53B |
| Novartis AG | 209.81B |
| AstraZeneca | 209.59B |